CA1024521A - 2,2-diaryl-cyclopropane amine derivatives - Google Patents
2,2-diaryl-cyclopropane amine derivativesInfo
- Publication number
- CA1024521A CA1024521A CA186,433A CA186433A CA1024521A CA 1024521 A CA1024521 A CA 1024521A CA 186433 A CA186433 A CA 186433A CA 1024521 A CA1024521 A CA 1024521A
- Authority
- CA
- Canada
- Prior art keywords
- formule
- dans
- est
- revendication
- groupe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 8
- 150000001412 amines Chemical class 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 18
- 238000010992 reflux Methods 0.000 claims description 15
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 8
- 150000001408 amides Chemical class 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 6
- 229910052759 nickel Inorganic materials 0.000 claims description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 3
- 229910010084 LiAlH4 Inorganic materials 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- ZXKINMCYCKHYFR-UHFFFAOYSA-N aminooxidanide Chemical compound [O-]N ZXKINMCYCKHYFR-UHFFFAOYSA-N 0.000 claims description 2
- 229940095054 ammoniac Drugs 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 241001644893 Entandrophragma utile Species 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 7
- 125000002252 acyl group Chemical group 0.000 abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 4
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- -1 atom hydrogen Chemical class 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229950011148 cyclopropane Drugs 0.000 description 27
- 229910052757 nitrogen Inorganic materials 0.000 description 25
- 230000004927 fusion Effects 0.000 description 23
- 206010002660 Anoxia Diseases 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 6
- 230000010412 perfusion Effects 0.000 description 5
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000699729 Muridae Species 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- AZJQILOIUQNKEZ-UHFFFAOYSA-N (2,2-diphenylcyclopropyl)methanamine Chemical compound NCC1CC1(C=1C=CC=CC=1)C1=CC=CC=C1 AZJQILOIUQNKEZ-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- MPFKAXRDUNPKDV-UHFFFAOYSA-N 2,2-bis(4-methylphenyl)cyclopropane-1-carboxylic acid Chemical compound C1=CC(C)=CC=C1C1(C=2C=CC(C)=CC=2)C(C(O)=O)C1 MPFKAXRDUNPKDV-UHFFFAOYSA-N 0.000 description 1
- HTXWKZDRDRFVHN-UHFFFAOYSA-N 2-methyloxiran-2-ol Chemical compound CC1(O)CO1 HTXWKZDRDRFVHN-UHFFFAOYSA-N 0.000 description 1
- AFPHTEQTJZKQAQ-UHFFFAOYSA-M 3-nitrobenzoate Chemical compound [O-]C(=O)C1=CC=CC([N+]([O-])=O)=C1 AFPHTEQTJZKQAQ-UHFFFAOYSA-M 0.000 description 1
- XRHGYUZYPHTUJZ-UHFFFAOYSA-M 4-chlorobenzoate Chemical compound [O-]C(=O)C1=CC=C(Cl)C=C1 XRHGYUZYPHTUJZ-UHFFFAOYSA-M 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- OVXZVDMCQPLHIY-QXGOIDDHSA-L calcium;4-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]butanoate Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O OVXZVDMCQPLHIY-QXGOIDDHSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229940028332 halog Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- 101150093826 par1 gene Proteins 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5527772A GB1409569A (en) | 1972-11-30 | 1972-11-30 | Amino derivatives of 2,2-diarylcyclopropane |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1024521A true CA1024521A (en) | 1978-01-17 |
Family
ID=10473459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA186,433A Expired CA1024521A (en) | 1972-11-30 | 1973-11-21 | 2,2-diaryl-cyclopropane amine derivatives |
Country Status (18)
Country | Link |
---|---|
US (1) | US3941833A (ru) |
AR (1) | AR203830A1 (ru) |
AT (1) | AT328423B (ru) |
BE (1) | BE807628A (ru) |
CA (1) | CA1024521A (ru) |
CH (1) | CH583175A5 (ru) |
CS (1) | CS186254B2 (ru) |
DD (1) | DD109861A5 (ru) |
DE (1) | DE2359796A1 (ru) |
DK (1) | DK136152B (ru) |
ES (1) | ES421015A1 (ru) |
FR (1) | FR2208662B1 (ru) |
GB (1) | GB1409569A (ru) |
HU (1) | HU168932B (ru) |
NL (1) | NL7316485A (ru) |
NO (1) | NO138562C (ru) |
SE (1) | SE397826B (ru) |
SU (1) | SU637077A3 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5123247A (ru) * | 1974-08-15 | 1976-02-24 | Sumitomo Chemical Co | |
US4103030A (en) * | 1974-12-11 | 1978-07-25 | Sumitomo Chemical Company, Limited | Novel cyclopropylmethylamine derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3098076A (en) * | 1958-08-26 | 1963-07-16 | Burroughs Wellcome Co | 1, 1-diphenyl-2-tertiary aminomethyl-3-hydroxy methyl-cyclopropanes and esters thereof |
FR2171947A1 (en) * | 1972-02-16 | 1973-09-28 | Hexachimie | Substd aminomethyl -2,2- diaryl cyclopropanes - for treating anxiety and cardiac insufficiency |
-
1972
- 1972-11-30 GB GB5527772A patent/GB1409569A/en not_active Expired
-
1973
- 1973-10-29 CH CH1518773A patent/CH583175A5/xx not_active IP Right Cessation
- 1973-11-13 FR FR7340329A patent/FR2208662B1/fr not_active Expired
- 1973-11-13 NO NO4356/73A patent/NO138562C/no unknown
- 1973-11-19 US US05/417,128 patent/US3941833A/en not_active Expired - Lifetime
- 1973-11-21 CA CA186,433A patent/CA1024521A/en not_active Expired
- 1973-11-22 BE BE2053235A patent/BE807628A/xx unknown
- 1973-11-28 AT AT996073A patent/AT328423B/de not_active IP Right Cessation
- 1973-11-28 HU HUHE646A patent/HU168932B/hu unknown
- 1973-11-29 SE SE7316179A patent/SE397826B/xx unknown
- 1973-11-29 DD DD174981A patent/DD109861A5/xx unknown
- 1973-11-29 SU SU731982652A patent/SU637077A3/ru active
- 1973-11-29 DK DK643773AA patent/DK136152B/da unknown
- 1973-11-29 AR AR251240A patent/AR203830A1/es active
- 1973-11-30 NL NL7316485A patent/NL7316485A/xx not_active Application Discontinuation
- 1973-11-30 CS CS7300008272A patent/CS186254B2/cs unknown
- 1973-11-30 DE DE2359796A patent/DE2359796A1/de not_active Withdrawn
- 1973-11-30 ES ES421015A patent/ES421015A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE807628A (fr) | 1974-03-15 |
CH583175A5 (ru) | 1976-12-31 |
NO138562C (no) | 1978-09-27 |
SE397826B (sv) | 1977-11-21 |
NO138562B (no) | 1978-06-19 |
GB1409569A (en) | 1975-10-08 |
SU637077A3 (ru) | 1978-12-05 |
FR2208662A1 (ru) | 1974-06-28 |
US3941833A (en) | 1976-03-02 |
DE2359796A1 (de) | 1974-06-12 |
ES421015A1 (es) | 1976-07-16 |
AT328423B (de) | 1976-03-25 |
HU168932B (ru) | 1976-08-28 |
CS186254B2 (en) | 1978-11-30 |
ATA996073A (de) | 1975-06-15 |
AR203830A1 (es) | 1975-10-31 |
NL7316485A (ru) | 1974-06-04 |
DK136152C (ru) | 1978-01-23 |
DD109861A5 (ru) | 1974-11-20 |
DK136152B (da) | 1977-08-22 |
FR2208662B1 (ru) | 1976-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH616148A5 (ru) | ||
KR100269727B1 (ko) | 2-(2,6-디-할로페닐아미노)페닐아세트산의 유도체의 니트릭에스테르 및 그들의 제조방법 | |
CA1181430A (en) | (-) - n-methyl-3-(2-methylphenox)-3-phenylpropylamine, antidepressant | |
FR2500450A1 (fr) | Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique | |
LU80880A1 (fr) | Derives d'alkylenediamines | |
CA1024521A (en) | 2,2-diaryl-cyclopropane amine derivatives | |
EP0174242B1 (fr) | Dérivés de 1-(aminophényl)-2-amino-propanone, leur utilisation en thérapeutique et leur procédé de préparation | |
EP0482183A1 (fr) | Nouveaux composes agonistes du recepteur h 3? de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation. | |
FR2646847A1 (fr) | N-phenyl amides, leurs procedes de preparation et les medicaments les contenant | |
CH644582A5 (fr) | Amides d'acide polyprenylcarboxylique. | |
FR2845991A1 (fr) | Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine | |
FR2643076A1 (fr) | Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline | |
CA2650480A1 (fr) | Composes de type 1, 4-naphtoquinones, compositions les comprenant et utilisation de ces composes en tant qu'agents anti -cancereux | |
FR2601363A1 (fr) | (dimethylamino)-2 ethyl) ((((methylthio)-2 phenyl) (phenylmethyl)amino)-2 oxo-2 ethyl) carbamates ou urees, leur preparation et leur application en therapeutique. | |
CH630606A5 (en) | Phenylamidine derivatives useful especially in therapeutics | |
EP1047664B1 (fr) | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EP0138684B1 (fr) | 2-(N-pyrrolidino)-3-isobutoxy-N-phenyl substitué N-benzyl propylamines, leur préparation et leur application pharmaceutique | |
CH635570A5 (fr) | Derives d'amino-alcools. | |
FR2693722A1 (fr) | Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant. | |
CH634311A5 (fr) | Derives du benzo(d)thiazole, leur procede de preparation et leurs applications en therapeutique. | |
EP0158545B1 (fr) | Dérivés d'acide [alpha-(alkylaminométhyl)-benzylthio]-acétique, procédé de préparation et utilisation en thérapeutique | |
EP0346419B1 (fr) | Derives d'amino-4 trifluoromethyl-1 tetralines, leur preparation et leur application en therapeutique | |
EP0097546B1 (fr) | Benzhydrylsulfinyléthylamines, procédé de préparation et utilisation en thérapeutique | |
EP0061379B1 (fr) | Dérivés de pyridine, leur préparation et leur application en thérapeutique | |
CA1098446A (fr) | Medicaments derives de l'indole |